Shikonin induces an anti ‑tumor effect on murine mammary cancer via p38‑dependent apoptosis.

In conclusion, shikonin is a potential anti‑tumor drug for breast cancer. PMID: 30664166 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research